Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications by Brian eGodman, Brian eGodman, Brian eGodman, Bjorn eWettermark, Bjorn eWettermark, Bjorn eWettermark, Menno eVan Woerkom, Jessica eFraeyman, Samantha eAlvarez-Madrazo, Christian eBerg, Iain eBishop, Anna eBucsics, Stephen eCampbell, Alexander E Finlayson, Jurij eFurst, Kristina eGaruoliene, Kristina eGaruoliene, Harald eHerholz, Marija eKalaba, Ott eLaius, Jutta ePiessnegger, Catherine eSermet, Ulrich eSchwabe, Vera eV Vlahović-Palčevski, Vanda eMarkovic-Pekovic, Vanda eMarkovic-Pekovic, Luka eVoncina, Kamila eMalinowska, Kamila eMalinowska, Corinne eZara, Lars L Gustafsson

Get full text

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimise the use of new drugs by Rickard eMalmstrom, Brian eGodman, Brian eGodman, Brian eGodman, Eduardo eDiogene, Christoph eBaumgaertel, Marion eBennie, Marion eBennie, Iain eBishop, Anna eBrzezinska, Anna eBucsics, Stephen eCampbell, Alessandra eFerrario, Alexander eFinlayson, Jurij eFurst, Kristina eGaruoliene, Miguel eGomes, Iñaki eGutiérrez-Ibarluzea, Alan eHaycox, Krystyna eHviding, Harald eHerholz, Mikael eHoffmann, Saira eJan, Jan eJones, Roberta eJoppi, Marija eKalaba, Christina eKvalheim, Ott eLaius, Irene eLangner, Julie eLonsdale, Sven-Ake eLoov, Kamila eMalinowska, Kamila eMalinowska, Laura eMcCullagh, Ken ePaterson, Vanda eMarkovic-Pekovic, Vanda eMarkovic-Pekovic, Andrew eMartin, Jutta ePiessnegger, Gisbert eSelke, Catherine eSermet, Steven eSimoens, Faik Cankat Tulunay, Dominik eTomek, Luka eVoncina, Vera eVlahovic-Palcevski, Janet eWale, Michael eWilcock, Magda eWladysiuk, Menno van Woerkom, Corrine eZara, Lars L Gustafsson

Get full text